Total Payments
$47,479
2024 Payments
$16,490
Companies
41
Transactions
752
Medicare Patients
7,341
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$24,963 (52.6%)
Other$14,738 (31.0%)
Consulting$3,400 (7.2%)
Research$2,895 (6.1%)
Travel$1,002 (2.1%)
Education$480.81 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,963 | 725 | 52.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,930 | 10 | 29.3% |
| Consulting Fee | $3,400 | 3 | 7.2% |
| Unspecified | $2,895 | 2 | 6.1% |
| Travel and Lodging | $1,002 | 3 | 2.1% |
| Honoraria | $808.11 | 2 | 1.7% |
| Education | $480.81 | 7 | 1.0% |
Payments by Type
General
$44,584
750 transactions
Research
$2,895
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $10,612 | 42 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $8,841 | 43 | $0 (2024) |
| ABBVIE INC. | $5,872 | 156 | $0 (2024) |
| LEO Pharma Inc. | $2,782 | 31 | $0 (2024) |
| Eli Lilly and Company | $2,388 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,285 | 44 | $0 (2024) |
| Allergan, Inc. | $1,669 | 60 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,387 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,258 | 17 | $0 (2024) |
| Lilly USA, LLC | $1,003 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,490 | 129 | Galderma Laboratories, L.P. ($9,778) |
| 2023 | $6,697 | 112 | Sun Pharmaceutical Industries Inc. ($2,906) |
| 2022 | $6,572 | 101 | Sun Pharmaceutical Industries Inc. ($3,893) |
| 2021 | $3,621 | 100 | AbbVie Inc. ($915.41) |
| 2020 | $4,415 | 64 | LEO Pharma Inc. ($2,132) |
| 2019 | $3,736 | 99 | AbbVie, Inc. ($776.95) |
| 2018 | $2,905 | 78 | AbbVie, Inc. ($735.99) |
| 2017 | $3,043 | 69 | AbbVie, Inc. ($684.94) |
All Payment Transactions
752 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Immunology | ||||||
| 12/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $120.88 | General |
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $198.67 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.76 | General |
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $133.35 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/04/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Inflammation & Immunology | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $30.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Inflammation & Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $2,388 | 1 |
| Retrospective Wound Care Case Series | Acera Surgical, Inc. | $506.25 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,511 | 8,339 | $1.1M | $422,323 |
| 2022 | 26 | 2,426 | 3,891 | $924,235 | $386,407 |
| 2021 | 25 | 1,340 | 2,240 | $510,114 | $233,421 |
| 2020 | 24 | 1,064 | 1,765 | $475,694 | $202,953 |
Total Patients
7,341
Total Services
16,235
Medicare Billing
$1.2M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 167 | 218 | $288,147 | $98,377 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 505 | 818 | $121,139 | $54,643 | 45.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 82 | 142 | $114,968 | $49,438 | 43.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 57 | 73 | $84,523 | $34,812 | 41.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 263 | 307 | $51,078 | $22,053 | 43.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 69 | 75 | $69,799 | $15,313 | 21.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 66 | 75 | $59,696 | $14,534 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 175 | 175 | $32,673 | $13,907 | 42.6% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 16 | 18 | $32,998 | $13,596 | 41.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 239 | 310 | $34,647 | $12,758 | 36.8% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 17 | 18 | $28,423 | $11,973 | 42.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 34 | 39 | $17,180 | $8,671 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 93 | $19,674 | $8,019 | 40.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 51 | 57 | $16,077 | $7,523 | 46.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 23 | 24 | $14,076 | $7,357 | 52.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 69 | 84 | $16,622 | $7,034 | 42.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 91 | 157 | $12,841 | $6,580 | 51.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 182 | 1,104 | $11,840 | $5,763 | 48.7% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 28 | 4,200 | $10,420 | $5,444 | 52.2% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 12 | $9,092 | $3,985 | 43.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 35 | 37 | $7,589 | $3,249 | 42.8% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $15,061 | $3,220 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,523 | $2,463 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 56 | $5,351 | $2,342 | 43.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $8,406 | $2,329 | 27.7% |
About Dr. Martin Zaiac, M.D
Dr. Martin Zaiac, M.D is a Specialist healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215979398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Zaiac, M.D has received a total of $47,479 in payments from pharmaceutical and medical device companies, with $16,490 received in 2024. These payments were reported across 752 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($24,963).
As a Medicare-enrolled provider, Zaiac has provided services to 7,341 Medicare beneficiaries, totaling 16,235 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatology, MOHS-Micrographic Surgery
- Location Miami Beach, FL
- Active Since 06/12/2006
- Last Updated 05/09/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1215979398
Products in Payments
- Odomzo (Drug) $5,600
- TALTZ (Drug) $3,259
- ENSTILAR (Drug) $2,555
- DUPIXENT (Biological) $2,262
- SKYRIZI (Biological) $2,178
- Humira (Biological) $1,467
- COSENTYX (Biological) $1,097
- Sotyktu (Drug) $949.31
- ODOMZO (Drug) $947.01
- Erivedge (Biological) $904.50
- Klisyri (Drug) $872.07
- DUPIXENT DUPILUMAB INJECTION (Biological) $812.76
- BOTOX (Biological) $669.66
- BOTOX COSMETIC (Biological) $590.90
- RINVOQ (Biological) $573.66
- Enbrel (Biological) $556.02
- Restrata Wound Matrix (Device) $526.32
- TREMFYA (Drug) $506.59
- Tremfya (Drug) $496.17
- Otezla (Drug) $474.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Miami Beach
Dr. Mike Cusnir, M.d, M.D
Specialist — Payments: $297,209
Specialist $297,209
Dr. Ettore Vulcano, M.d, M.D
Specialist — Payments: $236,418
Specialist $236,418
Juan Rivera, Md, MD
Specialist — Payments: $36,966
Specialist $36,966
Dr. Arnold Blaustein, M.d, M.D
Specialist — Payments: $34,776
Specialist $34,776
Dr. Michael Schwartz, M.d, M.D
Specialist — Payments: $33,081
Specialist $33,081
Dr. Roy Williams, Md, MD
Specialist — Payments: $27,690
Specialist $27,690